Literature DB >> 33399312

Prevalence and Trends in HIV Infection and Testing Among Adults in the United States: The National Health and Nutrition Examination Surveys, 1999-2018.

Geraldine M McQuillan1, Deanna Kruszon-Moran1, Silvina Masciotra2, Qiuping Gu1, Renee Storandt1.   

Abstract

BACKGROUND: HIV antibody testing has been included in the National Health and Nutrition Examination Survey, for ages 18-49 since 1999 and for ages 18-59 years since 2009 enabling estimation of trends in HIV prevalence as part of national surveillance in the U.S. household population. Self-reported HIV testing and antiretroviral use was also included in the survey since 1999.
SETTING: A continuous household-based probability sample of the U.S. population.
METHODS: From 1999 to 2018, 29,020 participants age 18-49 years were tested for HIV antibody and 34,092 participants age 18-59 years were asked about self-report of any previous HIV testing.
RESULTS: HIV prevalence was 0.41% among those aged 18-59 in 2009-2018 with a nonsignificant trend over time among those aged 18-49 years from 1999-2002 to 2015-2018. However, significant declines in prevalence were seen among those aged 18-39 years (0.37%-0.11%), women (0.22%-0.06%) and non-Hispanic black persons (2.14%-0.80%). Participants aged 18-39 years self-reported a decline in HIV testing, whereas those aged 40-49 and 50-59 years, non-Hispanic black persons and women reported an increase in getting a HIV test. Prevalence of infection and self-reported history of HIV testing varied by demographic and risk groups. HIV testing among HIV-positive persons was 83.9%. Antiretroviral therapy among those HIV-positive was under 50%.
CONCLUSION: Although total HIV prevalence and previous self-reported HIV testing remained stable for the last 20 years, there were significant declines in age and demographic subgroups. Prevalence for both outcomes varied by demographic and risk variables.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33399312      PMCID: PMC7933054          DOI: 10.1097/QAI.0000000000002618

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  7 in total

1.  Prevalence of HIV in the US household population: the National Health and Nutrition Examination Surveys, 1988 to 2002.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Benny J Kottiri; Laurie A Kamimoto; Lee Lam; M Faye Cowart; Marjorie Hubbard; Thomas J Spira
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-15       Impact factor: 3.731

2.  National Center for Health Statistics Data Presentation Standards for Proportions.

Authors:  Jennifer D Parker; Makram Talih; Donald J Malec; Vladislav Beresovsky; Margaret Carroll; Joe F Gonzalez; Brady E Hamilton; Deborah D Ingram; Kenneth Kochanek; Frances McCarty; Chris Moriarity; Iris Shimizu; Alexander Strashny; Brian W Ward
Journal:  Vital Health Stat 2       Date:  2017-08

3.  HIV Infection in U.S. Household Population Aged 18-59: Data From the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Joseph Woodring; Deanna Kruszon-Moran; Geraldine McQuillan
Journal:  Natl Health Stat Report       Date:  2015-09-24

4.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.

Authors:  F K Lee; L Pereira; C Griffin; E Reid; A Nahmias
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

5.  Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.

Authors:  Bernard M Branson; H Hunter Handsfield; Margaret A Lampe; Robert S Janssen; Allan W Taylor; Sheryl B Lyss; Jill E Clark
Journal:  MMWR Recomm Rep       Date:  2006-09-22

6.  Seroprevalence of HIV in the US Household Population Aged 18–49 Years: The National Health and Nutrition Examination Surveys, 1999–2006.

Authors:  Geraldine M McQuillan; Deanna Kruszon-Moran; Timothy Granade; Jane W Feldman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

7.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.

Authors:  R L Ashley; J Militoni; F Lee; A Nahmias; L Corey
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

  7 in total
  1 in total

1.  HIV prevalence among transmasculine individuals at a New York City Community Health Centre: a cross-sectional study.

Authors:  Asa E Radix; Elaine L Larson; Alexander B Harris; Mary Ann Chiasson
Journal:  J Int AIDS Soc       Date:  2022-10       Impact factor: 6.707

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.